Chemokine receptor antagonists and methods of use thereof
US7271176B2 · kind B2 · utility
7Cited by
46References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 13, 2002 |
| Grant date | Sep 18, 2007 |
| Priority date | — |
| Expiry date | Nov 13, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.